Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in South Korea / NCT01524276
Recruiting Observational

Product Surveillance Registry

NCT01524276 · tracked via the Priya Life Science South Korea tracker
Sponsor
Medtronic
Phase
Observational
Started
2012-01
Last updated
2026-09-18

Condition(s) studied

Cardiac Rhythm DisordersUrological DisordersNeurological DisordersCardiovascular DisordersDigestive DisordersIntracranial AneurysmMechanical Circulatory SupportRespiratory TherapyAortic, Peripheral Vascular and Venous DisordersMinimally Invasive Surgical ProceduresDiagnostic Techniques and ProceduresSurgical Procedures, OperativeRenal InsufficiencyNeurovascularCoronary Artery DiseaseEar, Nose and Throat Disorder

Study summary

The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements * Patient has or is intended to receive or be treated with an eligible Medtronic product * Patient within enrollment window relative to therapy initiation or meets criteria for retrospective enrollment Exclusion Criteria: * Patient who is, or will be, inaccessible for follow-up * Patient with exclusion criteria required by local law * Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results

Primary outcome measure(s)

  • Safety and Effectiveness of Market Released products — Every 6-12 months (Therapy-dependent)

Trial sites (401)

FacilityCityRegionStatus
— Birmingham Alabama Recruiting
— Huntsville Alabama Recruiting
— Chandler Arizona Recruiting
— Phoenix Arizona Recruiting
— Little Rock Arkansas Recruiting
— Aliso Viejo California Recruiting
— Chula Vista California Recruiting
— Colton California Recruiting
— La Jolla California Recruiting
— Los Angeles California Recruiting
— Napa California Recruiting
— Redwood City California Recruiting
— Salinas California Recruiting
— San Diego California Recruiting
— Stanford California Recruiting
— Torrance California Recruiting
— Ventura California Recruiting
— Aurora Colorado Recruiting
— Colorado Springs Colorado Recruiting
— Lakewood Colorado Recruiting
— Darien Connecticut Recruiting
— Hartford Connecticut Recruiting
— New Haven Connecticut Recruiting
— Washington D.C. District of Columbia Recruiting
— Bradenton Florida Recruiting
— Clearwater Florida Recruiting
— Davie Florida Recruiting
— Jacksonville Florida Recruiting
— Naples Florida Recruiting
— Panama City Florida Recruiting
— Safety Harbor Florida Recruiting
— Sarasota Florida Recruiting
— Tampa Florida Recruiting
— Weston Florida Recruiting
— Gainesville Georgia Active Not Recruiting
— Chicago Illinois Recruiting
— Evansville Indiana Recruiting
— Indianapolis Indiana Recruiting
— Iowa City Iowa Recruiting
— West Des Moines Iowa Recruiting

+ 361 more sites — see the full list on the official registry below.

More Medtronic trials in South Korea

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products Recruiting

Other trials for the same condition

Clinical Impact of Orsiro™ Stent in Patient With Chronic Kidney Disease Active, not recruiting
The COMPLETE Treatment of Bifurcation With Two-stent Techniques: Randomized Comparison of Crush Versus Culotte Technique Recruiting
CREATE Trial, Prospective, Observational Study Active, not recruiting
Study of the Natural History of FFR Guided Percutaneous Coronary Intervention Recruiting
Safety and Efficacy of Paclitaxel Coated PTCA Balloon Catheter With a Shellac Plus Vitamin E Excipient (GENOSS® DCB) in Patients With Coronary In-stent Restenosis (ISR): A Prospective, Multi-center, Observational Study Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT01524276 on ClinicalTrials.gov ↗ ← All trials in South Korea